Sign In
Buy PETV
$0.726
+0.0557 (+8.31%)
At Close: Jun 03, 2026
PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States
08:00am, Monday, 11'th Dec 2023
MINNEAPOLIS, MN, US, Dec. 11, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company"), an emerging biomedical device company focused on the commercialization of innovati
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California
11:00am, Tuesday, 21'st Nov 2023
MINNEAPOLIS, MN, US, Nov. 21, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative
PetVivo Holdings, Inc. (PETV) Q2 2024 Earnings Call Transcript
06:46pm, Tuesday, 14'th Nov 2023
PetVivo Holdings, Inc. (NASDAQ:PETV ) Q2 2024 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer & General Counsel John Lai - Ch
PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
03:00pm, Tuesday, 14'th Nov 2023
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commerci
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2023
08:00am, Thursday, 09'th Nov 2023
MINNEAPOLIS, MN, US, Nov. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical the
PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C.
08:00am, Tuesday, 05'th Sep 2023
MINNEAPOLIS, Sept. 05, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE FIRST QUARTER ENDED June 3, 2023
01:50pm, Monday, 07'th Aug 2023
MINNEAPOLIS, MN, US, Aug. 07, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical the
PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023
06:59pm, Thursday, 29'th Jun 2023
MINNEAPOLIS, MN, US, June 29, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical the
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
09:26am, Tuesday, 27'th Jun 2023
Developmental biomedical device company PetVivo Holdings Inc. OTCMKTS: PETV makes pet medical devices and therapeutics. What kind of medical devices would pets need?
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2023 ENDED MARCH 31, 2023
02:25pm, Monday, 26'th Jun 2023
MINNEAPOLIS, MN, US, June 26, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical the
PETVIVO HOLDINGS, INC. TO PRESENT AT AEGIS CAPITAL VIRTUAL CONFERENCE ON MAY 2-4, 2023
08:00am, Thursday, 27'th Apr 2023
MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical t
PetVivo Holdings, Inc. (PETV) Q3 2023 Earnings Call Transcript
08:25pm, Thursday, 09'th Feb 2023
PetVivo Holdings, Inc. (NASDAQ:PETV ) Q3 2023 Earnings Conference Call February 9, 2023 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer and General Counsel John Lai - P
PetVivo Holdings, Inc. to Present at Sequire Virtual Small Cap Conference on December 8th, 2022
11:25am, Monday, 05'th Dec 2022
MINNEAPOLIS, MN, Dec. 05, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative me
PetVivo Holdings, Inc. (PETV) Q2 2023 Earnings Call Transcript
06:26am, Saturday, 12'th Nov 2022
PetVivo Holdings, Inc. (NASDAQ:PETV ) Q2 2023 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants John Dolan – Chief Business Development Officer and General Counsel John Lai
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR SECOND QUARTER ENDED September 30, 2022
03:50pm, Thursday, 03'rd Nov 2022
MINNEAPOLIS, MN, US, Nov. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical the
